SCHEMBL107807

SCHEMBL107807

CN(C)c1cccc2c(S(=O)(=O)NCCCCCCN)cccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.69
HDAC10 Q969S8 1/20 0.69
HDAC6 Q9UBN7 1/20 0.69
HDAC5 Q9UQL6 1/20 0.69
CYP3A4 P08684 5/20 0.67
CYP1A2 P05177 4/20 0.67
CYP2C9 P11712 4/20 0.67
CYP2C19 P33261 4/20 0.67
TP53 P04637 4/20 0.67
CYP2D6 P10635 3/20 0.67
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
MAPK1 P28482 3/20 0.67
TSHR P16473 2/20 0.67
ALDH1A1 P00352 2/20 0.67
THPO P40225 2/20 0.67
TDP1 Q9NUW8 1/20 0.67
MAPT P10636 1/20 0.67
ALOX15 P16050 1/20 0.67
FPR2 P25090 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6361662 1.00 HDAC4 (0.69) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL17312330 1.00 HDAC4 (0.69) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL29729303 1.00 HDAC4 (0.69) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL107806 1.00 HDAC4 (0.69) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL5384708 0.99 HDAC4 (0.67) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL28265897 0.95 HDAC4 (0.64) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL8488157 0.95 HDAC4 (0.65) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL28267305 0.94 CYP3A4 (0.63) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL4126349 0.94 HDAC4 (0.62) HDAC4HDAC10HDAC6HDAC5CYP3A4
SCHEMBL4142506 0.93 HDAC4 (0.77) HDAC4HDAC10HDAC6HDAC5CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2602 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3411059-B1 METHOD TO ENHANCE THE EFFICIENCY OF SYSTEMIC AAV GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM UNIV MASSACHUSETTS (US) 2026-05-06 EP claimed
CN-113454099-B Detection of colonography in vivo using near infrared peptides targeting over-expression of cMET 密歇根大学董事会 2025-05-27 CN claimed
US-11826433-B2 Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system UNIVERSITY OF MASSACHUSETTS (US) 2023-11-28 US claimed
WO-2023164252-A1 ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2023-08-31 WO claimed
US-20220193271-A1 DETECTION OF COLONIC NEOPLASIA IN VIVO USING NEAR-INFRARED PEPTIDE TARGETED AGAINST OVEREXPRESSED CMET THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2022-06-23 US claimed
CN-113454099-A Detection of colon neoplasia in vivo using near infrared peptides targeted to overexpress cMET 密歇根大学董事会 2021-09-28 CN claimed
US-20210041421-A1 PLATFORM FOR ASSESSMENT OF THE TRANSCYTOSIS OF EXTRACELLULAR VESICLES ACROSS ENDOTHELIAL BARRIERS AND USES THEREOF CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-02-11 US claimed
EP-3565904-A1 ANALYSIS SYSTEM FOR ORTHOGONAL ACCESS TO AND TAGGING OF BIOMOLECULES IN CELLULAR COMPARTMENTS Illumina, Inc. (US) 2019-11-13 EP claimed
EP-2307877-B1 METHOD FOR DETECTING CARBOXYLIC FUNCTIONAL GROUPS UNIV AIX MARSEILLE (FR) 2019-11-13 EP claimed
US-20190323003-A1 ANALYSIS SYSTEM FOR ORTHOGONAL ACCESS TO AND TAGGING OF BIOMOLECULES IN CELLULAR COMPARTMENTS ILLUMINA, INC. (US) 2019-10-24 US claimed
EP-0754189-B1 RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO RECEPTAGEN CORP (US) 2002-10-09 EP claimed
US-20020077456-A1 Process for producing an amide compound NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) 2002-06-20 US claimed
EP-1199312-A2 Process for producing an amide compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-04-24 EP claimed
US-6322996-B1 REACTING A PHYSIOLOGICALLY ACTIVE PROTEIN WITH AN AMINO GROUP DONOR OR ALKYLAMINE-CONTAINING POLYSACCHARIDE IN PRESENCE OF TRANSGLUTAMINASE, THEREBY MODIFYING PROTEIN BY FORMING AN AMIDO LINKAGE BETWEEN CARBOXYAMIDE GROUP OF GLUTAMINE RESIDUE DRUG DELIVERY SYSTEM INSTITUTE, LTD. (JP) 2001-11-27 US claimed
WO-1998004245-A1 USE OF TRANSGLUTAMINASE MODULATORS TO PROMOTE WOUND HEALING THE VICTORIA UNIVERSITY OF MANCHESTER (GB) 1998-02-05 WO claimed
EP-0725145-A1 METHOD OF MODIFYING PROTEIN DRUG DELIVERY SYSTEM INSTITUTE, LTD. (JP) 1996-08-07 EP claimed
US-5541633-A Ink jet printing of concealed images on carbonless paper XEROX CORPORATION (US) 1996-07-30 US claimed
US-5308774-A Deproteinization, transferring and desorption HITACHI, LTD. (JP) 1994-05-03 US claimed
US-5286286-A Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores XEROX CORPORATION (US) 1994-02-15 US claimed
WO-1991010427-A2 THE EFFECT OF TRANSGLUTAMINASE INHIBITION ON MICROFILARIAE DEVELOPMENT AND MACROFILARIAE VIABILITY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1991-07-25 WO claimed